Transcatheter aortic valve replacement in severe aortic stenosis a review of comparative durability and clinical effectiveness beyond 12 months
Transcatheter aortic valve replacement (TAVR), sometimes called transcatheter aortic valve implantation (TAVI), was developed as an alternative for patients with severe aortic stenosis, who require aortic valve replacement but who are not eligible for conventional surgical aortic valve replacement (...
| Main Authors: | , , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
[2013], 2013
|
| Series: | Rapid response report: peer-reviewed summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references